ClinicalTrials.gg
CompletedNCT06242769Updated Feb 5, 2024

Clinical Research Study to Evaluate the Stain Removal Efficacy

A Phase 3 interventional study of Stannous Fluoride Toothpaste (SnF) and Colgate Fluoride Toothpaste (CDC) in Tooth Stain Removal, sponsored by Colgate Palmolive. Completed at 1 site in Puerto Rico. Open to participants aged 21 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-05.

Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Primary completion was Sep 2020, 6 years 2 months ago, and no results have been posted to the registry.
  • Registered 3 years 6 months after the study started (first participant enrolled Jul 2020, registered Jan 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
21 Years to 70 Years
Sex
All
01

Study summary

The objective of this clinical research study is to evaluate the stain removal efficacy of a toothpaste containing stannous fluoride as compared to negative control toothpaste in adults.

02

Conditions studied

  • Tooth Stain Removal

Keywords

  • Composite Lobene
  • extrinsic stain
03

In context

Lead sponsor

Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed Form
  • Good general health
  • Male and female subjects, aged 21-70, inclusive
  • Present 12 scoreable natural anterior teeth
  • A minimum mean Composite Lobene Index score of 1 or greater
  • Available for the duration of the study
  • Clinical evidence of a tendency to form extrinsic stain on anterior teeth

Exclusion criteria

Exclusion Criteria:

  • Presence of orthodontic bands
  • Presence of partial removable dentures
  • Tumor(s) of the soft or hard tissues of the oral cavity
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone)
  • Five or more carious lesions requiring immediate restorative treatment
  • Use of antibiotics or stain inducing medications any time during the one month prior to entry into the study
  • Participation in any other clinical study or test panel within the one month prior to entry into the study
  • Self-reported pregnancy and/or women who are breast feeding
  • Dental prophylaxis received in the past four weeks prior to baseline examinations
  • History of allergies to oral care/personal care consumer products or their ingredients, including allergies to hydrogen peroxide
  • On any prescription medicines that might interfere with the study outcome
  • History of alcohol and/or drug abuse
  • Exposed to a tooth whitening procedure during the last 3 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
80 participants (actual)

Study arms

  • Active comparator
    Group I

    Stannous Fluoride Toothpaste (SnF) Colgate Adult Extra Clean soft-bristle toothbrush brushing 2 X day for 2 min

    Drug: Stannous Fluoride Toothpaste (SnF) · Drug: Colgate Fluoride Toothpaste (CDC)

  • Placebo comparator
    Group II

    Fluoride Toothpaste (CDC) Colgate Adult Extra Clean soft-bristle toothbrush brushing 2 X day for 2 min

    Drug: Stannous Fluoride Toothpaste (SnF) · Drug: Colgate Fluoride Toothpaste (CDC)

Interventions

06

What researchers measure

Primary outcomes

  1. Composite Lobene Stain Index

    subjects will be evaluated for tooth stain by the dental examiner

    Time frame: measurement at baseline, 3 week & 6 week

07

Study locations

1 site
  • Dental Research Associates, Inc.
    San Juan, 00927, Puerto Rico
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2020 to primary completion in Sep 2020, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2024
First posted
Feb 5, 2024
StartActual
Jul 27, 2020
Primary completionActual
Sep 14, 2020
CompletionActual
Sep 14, 2020
Last update
Feb 5, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06242769
Lead sponsor
Colgate Palmolive
Responsible party
Sponsor
First posted
Feb 5, 2024
Start date
Jul 27, 2020
Primary completion
Sep 14, 2020
Completion
Sep 14, 2020
Last update
Feb 5, 2024

Study contacts

Augusto R Elias-Boneta, DMD, MSD
principal investigator · Dental Research Associates, Inc

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Tin Fluorides

Start the discussion